Choosing the Right Drug Name
Tuesday, July 22, 2014 • 1:30 p.m. - 3:00 p.m. EDT
The FDA rejects 40% of the drug names presented to it each year.
Not surprisingly, the drug industry has long criticized the agency about its name approval process.
So, in May 2014, the FDA released a draft guidance that covers the selection and approval process for proposed names of both prescription and nonprescription human drugs and biologics. In the guidance, the FDA describes its own review processes in detail and lays out 4 steps your company should follow in choosing a drug name.
To address this issue, FDAnews has teamed with drug-naming expert Dr. Susan Proulx to present a 90-minute webinar that will look closely at the draft guidance and its recommended 4-step process. Dr. Proulx will provide ideas on how to win the FDA’s approval for your suggested drug name.
BONUS HANDOUT: Attendees will receive their own copy of a chart that compares drug name approval regulations in the US and Canada.
And you'll learn more about the following:
Choosing the Right Drug Name: How to Increase Your Chances for Approval is sure to be a presentation you won't want to miss.
Register now for this can't-miss July 22 event. It's a very small investment in time and money … that might save your company millions.